A previous study showed that the natural compounds used in the present study inhibited IL-10- or IL-6-induced STAT3 activation in macrophages [39–44]; however, the effects of these natural compounds on MDCS-induced STAT3 activation in SCLC cells are unknown. The gene discussed is STAT3; the disease is small cell lung carcinoma.